Technological Landscapes
Technological Landscapes: Advanced Intravenous Iron-Deficiency-Anemia Therapy
Lexington-based AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron-deficiency-anemia.
There are diseases and then there are super-diseases. To visualize the scope of diseases that affect millions is almost incomprehensible. To visualize the scope of super-diseases that affect billions of people staggers the mind. When a disease impacts the lives of one out of three people on the entire Earth it is apocalyptic. Yet, that is the scourge of iron-deficiency-anemia (IDA). According to the Mayo Clinic, IDA (low red-blood-cell levels) is characterized by extreme fatigue, weakness, poor appetite, shortness of breath, headache, dizziness and lightheadedness. The result is a loss of work efficiency, pregnancy issues, increased risk of death for children, and deteriorated physical and cognitive development. As more and more people …
In this Article:
